IRIS Accounts Production v25.2.0.378 13111338 Board of Directors Board of Directors 1.11.23 31.10.24 31.10.24 false true false false false 34716 10633 120573 35297 35365 11214 119924 34716 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 13111338 2023-10-31 13111338 2024-10-31 13111338 2023-11-01 2024-10-31 13111338 2022-10-31 13111338 2022-11-01 2023-10-31 13111338 2023-10-31 13111338 ns15:EnglandWales 2023-11-01 2024-10-31 13111338 ns14:PoundSterling 2023-11-01 2024-10-31 13111338 ns10:Director1 2023-11-01 2024-10-31 13111338 ns10:Director2 2023-11-01 2024-10-31 13111338 ns10:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 13111338 ns10:Micro-entities 2023-11-01 2024-10-31 13111338 ns10:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 13111338 ns10:FullAccounts 2023-11-01 2024-10-31 13111338 ns10:Director2 42 2023-10-31 13111338 ns10:Director2 42 2022-10-31 13111338 ns10:Director2 42 2023-11-01 2024-10-31 13111338 ns10:Director2 42 2022-11-01 2023-10-31 13111338 ns10:Director2 42 2024-10-31 13111338 ns10:Director2 42 2023-10-31 13111338 ns5:CurrentFinancialInstruments 2024-10-31 13111338 ns5:CurrentFinancialInstruments 2023-10-31 13111338 ns5:Non-currentFinancialInstruments 2024-10-31 13111338 ns5:Non-currentFinancialInstruments 2023-10-31 13111338 ns10:RegisteredOffice 2023-11-01 2024-10-31 13111338 1 ns10:Director1 2023-10-31 13111338 1 ns10:Director1 2022-10-31 13111338 1 ns10:Director1 2023-11-01 2024-10-31 13111338 1 ns10:Director1 2022-11-01 2023-10-31 13111338 1 ns10:Director1 2024-10-31 13111338 1 ns10:Director1 2023-10-31

REGISTERED NUMBER: 13111338 (England and Wales)

| Unaudited Financial Statements |

| for the Year Ended 31 October 2024 |

| for |

| The Oncology & Plastic Surgery Clinic |

| Ltd |

| The Oncology & Plastic Surgery Clinic |

| Ltd (Registered number: 13111338) |

Contents of the Financial Statements

for the Year Ended 31 October 2024

Page |

| Balance Sheet | 1 |

| The Oncology & Plastic Surgery Clinic |

| Ltd (Registered number: 13111338) |

Balance Sheet

31 October 2024

| 31.10.24 | 31.10.23 |

£ | £ | £ | £ |

FIXED ASSETS | 52,187 |  | 58,341 |  |

CURRENT ASSETS | 683,926 |  | 394,765 |  |

CREDITORS

Amounts falling due within one year | (121,682 | ) | (58,071 | ) |

NET CURRENT ASSETS | 562,244 |  | 336,694 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 614,431 |  | 395,035 |  |

CREDITORS

Amounts falling due after more than one year | (10,235 | ) | (19,007 | ) |

NET ASSETS | 604,196 |  | 376,028 |  |

CAPITAL AND RESERVES | 604,196 |  | 376,028 |  |

NOTES TO THE FINANCIAL STATEMENTS

1. | STATUTORY INFORMATION

| The Oncology & Plastic Surgery Clinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

| Registered number: | 13111338

| Registered office: | Perrott House

| 17 Bridge Street

| Pershore

| Worcestershire

| WR10 1AJ

2. | AVERAGE NUMBER OF EMPLOYEES

| The average number of employees during the year was 2 (2023 - 2 ) .

| The Oncology & Plastic Surgery Clinic |

| Ltd (Registered number: 13111338) |

Balance Sheet - continued

31 October 2024

NOTES TO THE FINANCIAL STATEMENTS

3. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to directors subsisted during the years ended 31 October 2024 and 31 October 2023:

| 31.10.24 |  | 31.10.23

£ | £ |

| Dr S Irshad and A A Khan

| Balance outstanding at start of year | 34,716 |  | 10,633 |  |

| Amounts advanced | 120,573 |  | 35,297 |  |

| Amounts repaid | (35,365 | ) | (11,214 | ) |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | 119,924 |  | 34,716 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 28 October 2025 and were signed on its behalf by:

Dr S Irshad - Director

A A Khan - Director